Aug 2026· İstanbul Gelişim Üniversitesi sağlık bilimleri dergisi· pp. 153-162· 0 citations· 27 references
TL;DR
This narrative review defines the concept of DT from a healthcare perspective, summarizes its current applications in nutrition and dietetics, and outlines its high potential, key limitations, and challenges.
Abstract
Rapid advances in technology, particularly the integration of artificial intelligence (AI) technology into our lives, have increased interest in digital twin (DT) technology, which is a dynamic virtual model of a physical system. In the healthcare sector, DT is also seen as having the potential to bring about lasting transformation in areas such as drug development, advanced diagnostics and preventive treatment, clinical research, and personalized medicine. In the coming years, DT is expected to enable personalized nutrition by integrating genetic, epigenetic, microbiome, metabolic, immunological, and lifestyle data into comprehensive virtual models. This new paradigm has the potential to provide groundbreaking opportunities for the management and prevention of various nutrition-related diseases, obesity, and support healthy aging. Although early research in the field of nutrition is promising, various challenges and limitations persist, including data standardization, privacy, data quality and security, ethical concerns, high costs, scalability, and clinical validation issues. Currently, the use of DT in the field of nutrition and dietetics remains in the proof-of-concept stage. Nevertheless, it is anticipated that as these limitations are overcome over time, this technology will transform and guide global healthcare systems. This narrative review defines the concept of DT from a healthcare perspective, summarizes its current applications in nutrition and dietetics, and outlines its high potential, key limitations, and challenges.
Obesity is a complex, chronic, and heterogeneous disease that affects more than one billion people worldwide and represents one of the greatest public health challenges of the twenty-first century. Despite significant advances in pharmacotherapy, including glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual...
Alicja Włodarczyk, Hubert Łagosz, P. Wites et al.· International Journal of Inn...· 0 citations
The efficacy of incorporating artificial intelligence technologies into personalized recommendations for health improvement and symptom reduction in chronic diseases has been proven, with results demonstrating significant enhancements in patients' metabolic parameters and life quality.
Z. Burova, Maksym Hudzenko, Y. Kryzhova et al.· Human and nation s health· 0 citations
Although substantial technical, regulatory, and ethical challenges remain unresolved, ongoing progress in hybrid modeling, federated learning, explainable AI, and evolving regulatory frameworks provides a plausible pathway toward individualized prediction and proactive management, provided that claims of clinical readi...
Yue Sun, Ruo-Di Yang, Qi-Rui Xin et al.· Frontiers in Endocrinology· 0 citations
This study highlights HDTs as a paradigm shift with the potential to revolutionize healthcare delivery, improve patient outcomes, and enable a more proactive, data-driven model of care.
Somkene Okpala· International Journal of Med...· 0 citations
Cardiometabolic diseases remain a primary global health challenge, with nutritional interventions serving as a critical pillar of management. However, the rapidly expanding volume of nutritional research, spanning high-dimensional multiomics, real-world continuous monitoring, and highly heterogeneous clinical trials, h...
Q. Zheng, Jian-Guo Xu, Teng-Fei Li et al.· Frontiers in Nutrition· 0 citations
Advances in next-generation sequencing, artificial intelligence, and additive manufacturing have driven pharmacogenomic drug optimization, biomarker-guided targeted therapies, and on-demand production of customized dosage forms, but future progress depends on expanding genomic diversity, building curated multi-omics re...
Janhavi Patil, Diya H. Aga, Sneha Yadav et al.· Fabad journal of pharmaceuti...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.